BRCAura RUO
Research-use-only AI test assessing BRCA-related genomic risk signatures from pathology data, sold to research institutions rather than clinical end users.
Find alternatives to BRCAura RUO
Sold to research institutions under an RUO (research-use-only) label; no public price. Whether a recurring free tier exists is not stated either way.
What it does
- Data analysis
Sources
- Pricing
-
Official documentation · 14 Sep 2026
Sold to research institutions under an RUO (research-use-only) label; no public price. Whether a recurring free tier exists is not stated either way.
- Description
- What it does
- Sold within
-
Own page; RUO status confirmed in the product's own name and page copy -- sold to research institutions, not for clinical diagnostic use.
- Name
- URL
Also from Waiv
-
Destra Platform
Workflow platform that orchestrates Waiv's diagnostic tests within a lab's existing pathology workflow, handling sample intake, result delivery and reporting.
-
MSIntuit Suite Data service
Suite of AI diagnostic tests covering colorectal, endometrial and gastric cancer screening from pathology slides, marketed as one branded product line on Waiv's own site.
-
RlapsRisk BC Data service
CE-IVDR-cleared AI diagnostic test that predicts breast-cancer recurrence risk from routine pathology data, spun out of Owkin's diagnostics division.
Something wrong here? Send a correction — quote this product id: waiv-brcaura-ruo.